MICHAEL WARREN: Open Payments
NPI 1114329810 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 30 payments from 14 companies in 2025. Trend: 2023 $2,018 · 2024 $654 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $334 |
| Janssen Biotech, Inc. | 1 | $115 |
| Arcutis Biotherapeutics, Inc. | 1 | $68 |
| Galderma Laboratories, L.P. | 2 | $57 |
| PFIZER INC. | 3 | $55 |
| UCB, Inc. | 1 | $47 |
| Almirall LLC | 1 | $35 |
| Amgen Inc. | 1 | $22 |
| Biofrontera Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: SKYRIZI, TREMFYA, Zoryve, NEMLUVIO, CIBINQO, Bimzelx, Seysara, Otezla.
Industry payments across NY — which companies pay providers there.
